Researcher.Life Logo

JTO Clinical and Research Reports : Impact Factor & More

eISSN: 2666-3643
JournalOpen Access

Key Metrics

CiteScore
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JTO Clinical and Research Reports

JTO Clinical and Research Reports Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Article Processing ChargesUSD 2000
Publication Time19
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Association for the Study of Lung Cancer
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in JTO Clinical and Research Reports ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JTO Clinical and Research Reports

Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry.
  • 1 May 2026
  • JTO clinical and research reports
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study.
  • 1 May 2026
  • JTO clinical and research reports
Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With EGFR Mutation (West Japan Oncology Group 11719L: ADJUST Study).
  • 1 May 2026
  • JTO clinical and research reports
Patient-Derived Lung Cancer Organoids for Precision Oncology: A Comprehensive Analysis.
  • 1 May 2026
  • JTO clinical and research reports
Brief Report: Real-World Outcomes in Patients Living With Human Immunodeficiency Virus and Lung Cancer Treated With Immune Checkpoint Inhibitors.
  • 1 May 2026
  • JTO clinical and research reports
Yttrium-90 Radioembolization Versus Transarterial Embolization for Lung Carcinoid Hepatic Metastasis.
  • 1 May 2026
  • JTO clinical and research reports
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry.
  • 1 May 2026
  • JTO clinical and research reports
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study.
  • 1 May 2026
  • JTO clinical and research reports
Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With EGFR Mutation (West Japan Oncology Group 11719L: ADJUST Study).
  • 1 May 2026
  • JTO clinical and research reports
Patient-Derived Lung Cancer Organoids for Precision Oncology: A Comprehensive Analysis.
  • 1 May 2026
  • JTO clinical and research reports
Brief Report: Real-World Outcomes in Patients Living With Human Immunodeficiency Virus and Lung Cancer Treated With Immune Checkpoint Inhibitors.
  • 1 May 2026
  • JTO clinical and research reports
Yttrium-90 Radioembolization Versus Transarterial Embolization for Lung Carcinoid Hepatic Metastasis.
  • 1 May 2026
  • JTO clinical and research reports

FAQs on JTO Clinical and Research Reports